Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qihuang Yishen Granule
- Development stage
- Phase 3
- Lead developer
- China Academy of Chinese Medical Sciences
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Qihuang Yishen Granule (also known as TCM2501) is a traditional Chinese medicine (TCM) herbal formula developed as a hospital preparation by Wangjing Hospital of the China Academy of Chinese Medical Sciences, and licensed to Tasly for further clinical development. It is formulated from five traditional herbs: Huangqi (*Astragalus membranaceus*), Dihuang (*Rehmannia glutinosa*), Shanzhuyu (*Cornus officinalis*), Danshen (*Salvia miltiorrhiza*), and Danggui (*Angelica sinensis*). Qihuang Yishen Granule is primarily developed for the treatment of diabetic kidney disease (DKD) and diabetic nephropathy, where it aims to reduce proteinuria and alleviate renal fibrosis. Mechanistically, the formula has been shown to attenuate renal tubular injury and podocyte epithelial-mesenchymal transition (EMT) by downregulating the expression of lncRNA MALAT1, inhibiting the Wnt/β-catenin signaling pathway, and modulating inflammation via the cGAS/STING pathway.
- Other names
- QHYSQHYS GranulesQihuang Yishen FormulaQihuang Yishen Granules芪黄益肾方芪黄益肾颗粒
02
Targets
MALAT1 (Metastasis associated lung adenocarcinoma transcript 1)
Beyond the preview
Go deeper on Qihuang Yishen Granule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qihuang Yishen Granule.